Mural Oncology Plc4月25日成交额为113.38万美元

市场透视2025-04-26

美东时间2025年4月25日，Mural Oncology Plc（MURA.US）成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc（MURA.US）于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。|近5个交易日成交情况||||#|日期|成交额...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2530111313?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-26 10:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2530111313","market":"us","top_or_hot":-1,"title":"Mural Oncology Plc4月25日成交额为113.38万美元","media":"市场透视","content":"<div>\n<p>美东时间2025年4月25日，Mural Oncology Plc（MURA.US）成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc（MURA.US）于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。|近5个交易日成交情况||||#|日期|成交额...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Mural Oncology Plc4月25日成交额为113.38万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMural Oncology Plc4月25日成交额为113.38万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-26 10:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美东时间2025年4月25日，Mural Oncology Plc（MURA.US）成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc（MURA.US）于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。|近5个交易日成交情况||||#|日期|成交额...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MURA","symbol_name":"Mural Oncology","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","article_id":"2530111313","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426100545a6c8d0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2530111313","pubTimestamp":1745633136,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"美东时间2025年4月25日，Mural Oncology Plc成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MURA":"Mural Oncology","BK4139":"生物科技"},"translate_title":"Mural Oncology Plc turnover of $1,133,800 on April 25","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MURA":1},"content_text":"美东时间2025年4月25日，Mural Oncology Plc（MURA.US）成交额为113.38万美元，成交额较昨日减少45.98%，当日成交量为43.78万股。Mural Oncology Plc（MURA.US）于2025年4月25日跌1.52%，报2.6美元，该股过去5个交易日跌3.7%，年初至今跌19.25%，过去60日跌30.11%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|113.38万|-45.98%|43.78万|#|2025-04-24|209.89万|-14.14%|79.00万|#|2025-04-23|244.46万|-24.02%|88.56万|#|2025-04-22|321.75万|-11.96%|118.25万|#|2025-04-21|365.45万|-75.96%|137.59万|Mural Oncology PLC 是一家临床阶段的肿瘤公司，其整个业务都集中在发现和开发可能有意义地改善癌症患者生活的免疫疗法。通过利用其在免疫细胞调节和蛋白质工程方面的核心竞争力，该公司开发了一系列新颖的研究性细胞因子疗法，旨在解决各种癌症患者未满足的需求。其候选产品Nemvaleukin是一种在研的、工程化的白细胞介素-2细胞因子，旨在捕获和扩大高剂量重组人IL - 2的治疗益处，同时减轻其标志性毒性。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2530111313","isCrawlerRequest":true}